アプリをダウンロード
データなし
News On Mateon Therapeutics Inc. (MATN) Now Under OTLC
Dow Jones Newswires2021/03/31 17:09 ET
Mateon Therapeutics Initiated at Buy by Litchfield Hills
Dow Jones Newswires2020/12/07 07:35 ET
Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3
Benzinga Real-time News2020/12/07 07:25 ET
Mateon Therapeutics analyst ratings
Benzinga Analyst Ratings2020/12/07 07:24 ET